Coronary heart disease knowledge tool for women

被引:14
作者
Thanavaro, Joanne L. [1 ]
Thanavaro, Samer [2 ]
Delicath, Timothy [3 ]
机构
[1] St Louis Univ, Sch Nursing, St Louis, MO 63104 USA
[2] Christian NE Hosp, St Louis, MO USA
[3] Phoenix Univ, Phoenix, AZ USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS | 2010年 / 22卷 / 02期
关键词
Coronary heart disease; CHD knowledge tool; women; RISK; PREVENTION; AWARENESS;
D O I
10.1111/j.1745-7599.2009.00476.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: To develop a tool that measures coronary heart disease (CHD) knowledge specifically for women. Data sources: The new CHD knowledge tool, based on previous surveys of women's CHD knowledge, has 25 multiple-choice questions. An expert panel evaluated content and face validity. The tool was pilot tested in women without CHD, who were admitted to a Chest Pain Center. The tool was subsequently administered to laywomen and female cardiovascular nurses to evaluate its validity and reliability. The sample included 49 women as the control group (Group 1), 23 cardiovascular nurses as a known group (Group 2), and 22 women with an educational program as the treatment group (Group 3). Knowledge of women in Group 1 was compared with Groups 2 and 3 in known group and predictive validity tests. Conclusion: The new tool demonstrates good validity and reliability to measure CHD knowledge in women. Implications for practice: Women continue to have low CHD knowledge, and nurse practitioners should provide education to improve women's CHD knowledge as a strategy to promote healthy lifestyle practices and CHD risk prevention. The new tool can be utilized in future research to measure women's CHD knowledge.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 25 条
  • [1] *AM HEART ASS, 2000, WOM HEART DIS STUD T
  • [2] *AM HEART ASS, 2008, WOM CARD DIS STAT
  • [3] *AM NURS ASS, 1996, SCOP STAND ADV PRACT
  • [4] Berra Kathy, 2003, J Cardiovasc Nurs, V18, P85
  • [5] Gavin JR, 1999, DIABETES CARE, V22, pS5
  • [6] Hankinson S., 2001, HLTH WOMEN HLTH LIVE
  • [7] Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin
    Heiss, Gerardo
    Wallace, Robert
    Anderson, Garnet L.
    Aragaki, Aaron
    Beresford, Shirley A. A.
    Brzyski, Robert
    Chlebowski, Rowan T.
    Gass, Margery
    LaCroix, Andrea
    Manson, Joann E.
    Prentice, Ross L.
    Rossouw, Jacques
    Stefanick, Marcia L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (09): : 1036 - 1045
  • [8] Lange-Collett Jennifer, 2002, J Am Acad Nurse Pract, V14, P172, DOI 10.1111/j.1745-7599.2002.tb00109.x
  • [9] LEVY D, 2004, CARDIOCARE RISK REDU
  • [10] Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    Lloyd-Jones, Donald
    Adams, Robert
    Carnethon, Mercedes
    De Simone, Giovanni
    Ferguson, T. Bruce
    Flegal, Katherine
    Ford, Earl
    Furie, Karen
    Go, Alan
    Greenlund, Kurt
    Haase, Nancy
    Hailpern, Susan
    Ho, Michael
    Howard, Virginia
    Kissela, Brett
    Kittner, Steven
    Lackland, Daniel
    Lisabeth, Lynda
    Marelli, Ariane
    McDermott, Mary
    Meigs, James
    Mozaffarian, Dariush
    Nichol, Graham
    O'Donnell, Christopher
    Roger, Veronique
    Rosamond, Wayne
    Sacco, Ralph
    Sorlie, Paul
    Stafford, Randall
    Steinberger, Julia
    Thom, Thomas
    Wasserthiel-Smoller, Sylvia
    Wong, Nathan
    Wylie-Rosett, Judith
    Hong, Yuling
    [J]. CIRCULATION, 2009, 119 (03) : E21 - E181